NewTimeSpace News: MANYCORE TECH announced on July 2 that pursuant to its post-IPO restricted share unit scheme, the Company granted an aggregate of 1,130,000 restricted share units to 24 eligible employees at a nil subscription price.
NewTimeSpace News: PICC Group announced on July 2 that the Company has recently received an official reply from the State Administration of Financial Regulation, approving the appointment qualification of Mr. Zhang Daoming as Vice President of the Company.
NewTimeSpace News: Laekna, Inc. disclosed in a voluntary announcement dated July 2 that its Board of Directors approved an on-market share repurchase programme on July 1, 2026. Meanwhile, Dr. Lü Xiangyang, Chairman of the Board, and several senior management members plan to concurrently increase their holdings in the Company. The total maximum amount for the on-market buyback and senior management share purchases combined will be HK$56 million.
NewTimeSpace News: In a voluntary announcement dated July 2, SF Intra-city disclosed that between 1 September 2025 and 30 June 2026, the trustee purchased an aggregate of 19,113,800 shares in the market under the 2025 H-Share Incentive Scheme, at a total consideration of approximately HK$193 million.
NewTimeSpace News: In a voluntary announcement dated July 2, Abbisko disclosed that its subsidiary HORIZON Therapeutics entered into a strategic cooperation agreement with AstraZeneca to jointly conduct a multicenter, open-label Phase I/II clinical trial. The trial is designed to evaluate the safety and efficacy of ABSK043 (lumipodlin), the company’s proprietary first-in-class oral small-molecule PD-L1 inhibitor, in combination with AstraZeneca’s third-generation EGFR-TKI Tagrisso (osimertinib) for patients with EGFR-mutated, PD-L1-positive non-small cell lung cancer (NSCLC).
NewTimeSpace News: In a voluntary announcement dated July 2, Ribo Life Sciencedisclosed that the milestone of selecting the first candidate drug under its siRNA collaboration programme with Madrigal Pharmaceuticals has been accomplished, and IND-enabling studies will be launched immediately afterwards.
NewTimeSpace News: Ganfeng Lithium announced on July 2 that Mr. Wang Xiaoshen, a shareholder of the Company, pledged 5.7 million shares of the Company to Guotai Haitong Securities. The pledged shares account for 4.03% of his personal shareholding and 0.27% of the Company’s total issued share capital.
NewTimeSpace News: In a voluntary announcement dated July 2, SSY Group Limiteddisclosed that the Group has obtained the drug manufacturing registration approval for Methocarbamol Tablets (0.5g) issued by the National Medical Products Administration (NMPA). Meanwhile, the Group’s phloroglucinol active pharmaceutical ingredient (API) has been approved for registration as an API for use in marketed pharmaceutical preparations.
NewTimeSpace News: Leads Biolabsannounced on July 1 that pursuant to its H-share incentive scheme, the Company granted an aggregate of 2,254,691 share awards to 149 grantees.
NewTimeSpace News: CIMC Group announced on July 1 that CPIC Prudential Life, previously a shareholder holding more than 5% of the Company’s shares, reduced its holdings by disposing of 23,017,066 A-shares via centralized bidding trading between June 24 and June 29, 2026. Following the disposal, its shareholding ratio dropped from 5.43% to approximately 4.9999987%, ceasing to be a shareholder with a stake exceeding 5%.
NewTimeSpace News: JL MAG Rare-Earth released its 2026 half-year performance forecast on July 1, projecting net profit attributable to shareholders of the listed company ranging from RMB 400 million to RMB 460 million for the first half, representing a year-on-year increase of 31.17% to 50.84%.
NewTimeSpace News: Venus Medtech announced on July 2 that the Company entered into an investment term sheet with Hangzhou Hi-Tech Group and Hangzhou Yingzhiqin on July 1, 2026. The intended investors plan to invest in the Company via subscription for new shares and new convertible bonds, with a maximum total investment amount of RMB 500 million and a deposit of RMB 100 million.
NewTimeSpace News: Dynagreen Environmental Protection Group announced on July 2 that between April 1 and June 30, 2026, the principal amount of "Dynagreen Convertible Bonds" converted totalled RMB 1,000, corresponding to 112 converted shares.
NewTimeSpace News: In a voluntary announcement dated July 2, Bioheart disclosed that Bioheart® bioresorbable drug-eluting stent independently developed by the Company has obtained registration approval from the National Medical Products Administration (NMPA), indicated for the treatment of patients with ischaemic heart disease caused by de novo coronary artery lesions.
July 01, 2026, LK TECH(00558.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 5.61 billion, decreased by 3.71% YoY
MIDEA GROUP(00300.HK) will spend CNY 151.3 million to repurchase 1.99 million shares on Jul 1, 2026 .
